Bacterial skin infections in children hospitalized with varicella: A possible negative impact of non-steroidal anti-inflammatory drugs?

Acta Dermato-Venereologica

Volumn 88, Issue 1, 2008, Pages 26-30

  Dubos, François ^a,b   Hue, Valérie ^a   Grandbastien, Bruno ^a,b   Catteau, Benoît ^a   Martinot, Alain ^a,b   Akitani, ^c   Bajja, ^d   Blondiaux, ^e   Cixous, ^f   Delepoulle, ^g   Dorkenoo, ^h   Dumonceaux, ⁱ   El Kohen, ^j   Glowacki, ^k   Halna, ^h   Racoussot, ^l   Segal, ^m  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Seclin Hospital

^d Maubeuge Hospital

^e Cambrai Hospital

^f Roubaix Hospital

^g Dunkerque Hospital

^h Transversal Unit of Patient Education

ⁱ Valenciennes Hospital   (France)

^j Saint Vincent de Paul Medical Imaging   (France)

^k Armentières Hospital

^l Douai Hospital

^m Tourcoing Hospital

more..

Author keywords

Bacterial skin infection; Children; Hospitalization; Varicella

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; STEROID;

ARTICLE; CELLULITIS; CHICKENPOX; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECTHYMA; FEMALE; HOSPITAL PATIENT; HUMAN; IMPETIGO; INFANT; MALE; PRIORITY JOURNAL; RISK FACTOR; SCARLET FEVER; SKIN ABSCESS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS;

AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLULITIS; CHICKENPOX; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; FRANCE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL SKIN INFECTIONS; STATISTICS, NONPARAMETRIC;

EID: 38949083184     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0333     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Evaluation of varicella reporting to the National Notificable Disease Surveillance System - United States, 1972-1997. MMWR Morb Mortal Wkly Rep 1999; 48: 55-58.
2. Deguen S, Chau NP, Flahault A. Epidemiology of chicken-pox in France (1991-1995). J Epidemiol Community Health 1998; 52 Suppl 1: 46-49.
3. Yawn BP, Yawn RA, Lydick E. Community impact of childhood varicella infections. J Pediatr 1997; 130: 759-765.
4. Levrat V, Floret D. Caractéristiques cliniques des varicelles hospitalisées en réanimation pédiatrique de 1998 à 2001 en France. Bull Epidemiol Hebdom 2003; 9: 51-52.
5. Coplan P, Black S, Rojas C, Shinefield H, Ray P, Lewis E, et al. Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J 2001; 20: 641-645.
6. Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis 2000; 181: 1897-1905.
7. Gil A, Oyaguez I, Carrasco P, Gonzalez A. Epidemiology of primary varicella hospitalizations in Spain. Vaccine 2001; 20: 295-298.
8. Boelle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect 2002; 129: 599-606.
9. Dubos F, Hue V, Grandbastien B, the Hospital Network for Evaluating the Management of Common Childhood Diseases, Martinot A. Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect 2007; 135: 131-138.
10. Varughese PV. Chickenpox in Canada, 1924-87. CMAJ 1988; 138: 133-134.
11. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000; 182: 383-390.
12. Saddier P, Floret D, Guess HA, Durr F, Peyrieux JC, Weber DJ, et al. Cost of varicella in France: a study in day care centers. J Infect Dis 1998; 178 Suppl 1: 58-63.
13. Law B, Fitzsimon C, Ford-Jones L, McCormick J, Riviere M. Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program - Active (IMPACT). Pediatrics 1999; 104: 7-14.
14. Grimprel E, Levy C, de La Rocque F, Cohen R, Soubeyrand B, Caulin E, et al. Paediatric varicella hospitalisations in France: a nationwide survey. Clin Microbiol Infect. 2007; 13: 546-549.
15. Lesko SM, O'Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and non-steroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107: 1108-1115.
16. Zerr DM, Alexander R, Duchin JS, Koutsky LA, Rubens CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999; 103: 783-790.
17. Whitley RJ. Varicella-zoster virus. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th edn. Philadelphia: Elsevier, Inc., 2004: p. 1780-1786.
18. Peterson CL, Vugia DJ, Meyers HB, Chao SM, Vogt J, Lanson J, et al. Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J 1996; 15: 151-156.
19. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985; 152: 1172-1181.
20. Aebi C, Ahmed A, Ramilo O. Bacterial complications of primary varicella in children. Clin Infect Dis 1996; 23: 698-705.
21. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 2001; 108: e79.
22. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000; 105: e60.
23. Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue superinfections in children with varicella. Ann Epidemiol 1997; 7: 440-445.
24. Brogan TV, Nizet V, Waldhausen JH, Rubens CE, Clarke WR. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14: 588-594.
25. American Academy of Pediatrics. Committee on Infectious Diseases. Severe invasive group A streptococcal infections: a subject review. Pediatrics 1998; 101: 136-140.
26. Lesko SM. The safety of Ibuprofen suspension in children. Int J Clin Pract Suppl 2003; 135: 50-53.
27. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21: 977-980.
28. Cockerill FR 3rd, MacDonald KL, Thompson RL, Roberson F, Kohner PC, Besser-Wiek J, et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 1997; 277: 38-43.
29. Chaussee MS, Liu J, Stevens DL, Ferretti JJ. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996; 173: 901-908.
30. Descheemaeker P, Van Loock F, Hauchecorne M, Vandamme P, Goossens H. Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994. J Med Microbiol 2000; 49: 467-471.
31. Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, et al. Evidence for superantigen involvement in severe group A streptococcal tissue infections. J Infect Dis 2001; 184: 853-860.
32. Dubos F, Langlois-Meurinne HB, Hue V, Grandbastien B, Martinot A. Assessment of out-patient treatment of varicella in children. Presse Med 2004; 33: 992-996.
33. Rentier B, Gershon AA, European Working Group on Varicella. Consensus: varicella vaccination of healthy children - a challenge for Europe. Pediatr Infect Dis J 2004; 23: 379-389.
34. Coudeville L, Paree F, Lebrun T, Sailly J. The value of varicella vaccination in healthy children: costbenefit analysis of the situation in France. Vaccine 1999; 17: 142-151.